"The Report
Hyperkalemia Global Clinical Trials Review, H1, 2016 provides
information on pricing, market analysis, shares, forecast, and
company profiles for key industry participants. -
MarketResearchReports.biz"
GlobalData's clinical trial
report, Hyperkalemia
Global Clinical Trials Review, H1, 2016"
provides an overview of Hyperkalemia clinical trials scenario. This
report provides top line data relating to the clinical trials on
Hyperkalemia. Report includes an overview of trial numbers and their
average enrollment in top countries conducted across the globe. The
report offers coverage of disease clinical trials by region, country
(G7 & E7), phase, trial status, end points status and sponsor
type. Report also provides prominent drugs for in-progress trials
(based on number of ongoing trials). GlobalData Clinical Trial
Reports are generated using GlobalDatas proprietary database - Pharma
eTrack Clinical trials database. Clinical trials are collated from
80+ different clinical trial registries, conferences, journals, news
etc across the globe. Clinical trials database undergoes periodic
update by dynamic process.
The report enhances the
decision making capabilities and helps to create an effective counter
strategies to gain competitive advantage.
Download Sample copy of this
Report at:
Scope
-
The report provides a snapshot of the global clinical trials
landscape
-
Report provides top level data related to the clinical trials by
Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor
Type and End point status
-
The report reviews top companies involved and enlists all trials
(Trial title, Phase, and Status) pertaining to the company
-
The report provides all the unaccomplished trials (Terminated,
Suspended and Withdrawn) with reason for unaccomplishment
-
The Report provides enrollment trends for the past five years
-
Report provides latest news for the past three months.
Reasons to buy
-
Assists in formulating key business strategies with regards to
investment
-
Helps in identifying prominent locations for conducting clinical
trials which saves time and cost
-
Provides top level analysis of Global Clinical Trials Market which
helps in identifying key business opportunities
-
Supports understanding of trials count and enrollment trends by
country in global therapeutics market
-
Aids in interpreting the success rates of clinical trials by
providing a comparative scenario of completed and uncompleted
(terminated, suspended or withdrawn) trials
-
Facilitates clinical trial assessment of the indication on a global,
regional and country level.
Follow us on LinkedIn:
https://www.linkedin.com/company/marketresearchreports-biz
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average
Enrollment by Country 7
Top Countries Contributing to
Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing
to Clinical Trials in Europe 10
Top Countries Contributing to
Clinical Trials in North America 11
Top Countries Contributing to
Clinical Trials in Middle East and Africa 12
Clinical Trials by G7
Countries: Proportion of Hyperkalemia to Metabolic Disorders Clinical
Trials 13
Clinical Trials by Phase in G7
Countries 14
Clinical Trials in G7 Countries
by Trial Status 15
Clinical Trials by E7
Countries: Proportion of Hyperkalemia to Metabolic Disorders Clinical
Trials 16
Clinical Trials by Phase in E7
Countries 17
Clinical Trials in E7 Countries
by Trial Status 18
Clinical Trials by Phase 19
In Progress Trials by Phase 20
Clinical Trials by Trial Status
21
Clinical Trials by End Point
Status 22
Subjects Recruited Over a
Period of Time 23
Clinical Trials by Sponsor Type
24
Prominent Sponsors 25
Top Companies Participating in
Hyperkalemia Therapeutics Clinical Trials 26
Prominent Drugs 27
Latest Clinical Trials News on
Hyperkalemia 28
May 22, 2016: Data from New
Analyses of Studies with Veltassa Presented at 53rd European Renal
Association Congress 28
Apr 28, 2016: Data from New
Analyses of Studies with Veltassa Presented at National Kidney
Foundation 2016 Spring Clinical Meetings 28
Apr 21, 2016: Relypsa Announces
Upcoming Veltassa Data Presentations at National Kidney Foundation
2016 Spring Clinical Meetings 29
Clinical Trial Profile
Snapshots 31
Appendix 48
Abbreviations 48
Definitions 48
Research Methodology 49
Secondary Research 49
About us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
Mr.
Nachiket
State
Tower
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-621-2074
No comments:
Post a Comment